Tejal Desai

Dr. Tejal Desai is Chair and Professor of the Department of Bioengineering and Therapeutic Sciences in the School of Pharmacy at the University of California, San Francisco. Dr. Desai’s research brings together advanced micro and nanotechnologies, fundamental insight into cellular behavior in engineered environments, and novel pharmacologic delivery approaches to address disease treatment and clinical translation. Currently, her laboratory focuses on four highly interdisciplinary directions: 1. Hierarchical devices for enhanced cellular adhesion and paracellular drug transport; 2. Injectable and flexible nanoporous devices for rate-controlled long term release of therapeutics; 3. Nanostructured coatings and scaffolds for pro-healing implants and in vivo modulation of fibrosis, and 4. Cell-based delivery platforms for autoimmune disease applications. She envisions a future of precision medicine, enabled by advances in nanotechnology, engineering, and cell biology directed to clinical challenges in disease treatment. By taking advantage of our understanding of how cells respond to engineered materials and our ability to fabricate precise structural domains, her lab seeks to design new platforms to overcome existing challenges in therapeutic delivery.